The very rare but sometimes deadly clots led to pauses in the vaccine's rollout early this year in Europe, and had public health experts worried it could fuel hesitancy, even as they stressed that the benefits of the vaccine far outweighed any risks.
from Google Alert - health https://ift.tt/3Ehaxij
via IFTTT
0 comments:
Post a Comment